"Some of the things that we get regularly are around not being confident with people who are used to being bullied or picked ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...

Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

What: At this oil painting craft for adults, Nina will lead you in creating your own work ... Jenelle from Rootz and Branchez ...

A care home for adults ... small group living model, Exemplar Health Care has found it can provide a far more supportive environment that is more responsive to people’s needs. The home also features ...

The care home supports adults living with complex mental health needs, dementia, neuro-disabilities, and physical ...

Avenue Therapeutics, Inc. (Nasdaq: ATXI) ("Avenue" or the "Company"), a specialty pharmaceutical company focused on the development and commercialization of therapies ...

Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

To qualify for for short-term rehab services in a skilled nursing facility – and to qualify for Medicare coverage – patients ...

TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...

About half of the estimated 15.5 million American adults who have ADHD were diagnosed during adulthood. UAB’s Rachel Fargason ...